CIS Launches Suite of Commercialization Services at New PA Bio Fall Conference
CIS announced the launch of its Emergent BioPharma Insights™ commercial solutions for clinical stage companies at Pennsylvania Bio's Life Sciences Future 2013.
- Philadelphia, PA-NJ (1888PressRelease) November 14, 2013 - Compliance Implementation Services (CIS), a leading life sciences consulting firm, today announced the launch of its Emergent BioPharma Insights™ commercial solutions for clinical stage companies at Pennsylvania Bio's Life Sciences Future 2013. Earlier this year CIS hired Neil DeHenes, Senior Director, Commercialization Services, and Tom Evegan, Senior Director, Commercial Contracting Services, to lead its Commercialization team as part of its ongoing effort to provide Commercialization Strategy and Operational Support to clients.
The path from product development toward commercialization is challenging for clinical stage companies who must balance limited resources, competing priorities and a tough regulatory approval process. As these companies hit clinical trial endpoints and progress through phase II and III studies, their leaders come to a strategic business decision of whether to pursue partnerships and out-licensing opportunities or continue down the path of retaining control over the product they have worked hard to develop by pursuing their own commercialization strategies. CIS advises leaders in this decision by providing proactive analysis, strategy and planning that considers all the commercial implications of their product in a changing healthcare landscape.
"CIS works regularly with clinical stage companies to help them prepare for and achieve successful commercialization," said DeHenes. "Our regulatory knowledge and proven methodology allows clients to focus on core competencies, while our subject matter experts take on the day-to-day challenges of commercial activities."
CIS provides holistic commercialization services and post-launch operational support through a unique service-based approach that combines analytical skills and proven methodologies, proprietary systems and industry experts. CIS specializes in developing and implementing commercialization strategies and supporting commercial operations during pre- and post-launch:
• Gross-to-Net Value Analysis
• GCP and GMP Risk Analysis and Pre-Submission Compliance
• Compliance Program Design and Operational Governance
• Channel Strategy and Patient Access Program Development
• Commercial and Federal Contracting Strategy
• Government Programs Strategy and Administration
About Compliance Implementation Services (CIS)
Compliance Implementation Services (CIS) is a consulting firm focused on helping life sciences clients proactively manage complex compliance requirements. We offer a broad portfolio of services and solutions that expand deep into the clinical, manufacturing and commercial disciplines and that align with our clients' strategic priorities and business operations. CIS continually provides leadership, global regulatory knowledge, industry experience and a problem-solving culture that responds to today's compliance and commercial challenges. For more information, visit www.cis-partners.com.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam